New research on Hyperbaric Oxygen Therapy Treatment (HBOT) for traumatic brain injury (TBI) and Post Traumatic Stress Disorder (PTSD) was presented at the 8th World Congress on Brain Injury in Washington DC.
A study on Hyperbaric Oxygen Therapy (HBOT) in veterans wight blast-induced traumatic brain injury (TBI) and post traumatic stress (PTSD) was conducted by Dr. Paul G. Harch and colleagues at LSU School of Medicine New Orleans, the University of North Dakota School of Medicine, and the University of California, Irvine, School of Medicine and Amen Clinics. Sixteen active duty and retired U.S. veterans were treated with HBOT nearly three years after brain injuries and PTSD caused by improvised explosive device (IED) and rocket-propelled grenade explosions. All veterans had been diagnosed by military and/or civilian specialists with PCS and PTSD before entering the New Orleans study. Diagnoses confirmed by study authors before treatment.
HYPERBARIC OXYGEN THERAPY IN THE TREATMENT OF CHRONIC TRAUMATIC BRAIN INJURY:
FROM LOUISIANA BOXERS TO U.S. VETERANS, AN AMERICAN CHRONOLOGY
PAUL G. HARCH, M.D.
CLINICAL ASSOCIATE PROFESSOR
LSU SCHOOL OF MEDICINE, NEW ORLEANS
The application of hyperbaric oxygen therapy (HBOT) to chronic traumatic brain injury (TBI) can be traced to clinical practice and research in South Florida and New Orleans, Louisiana. It is well known that the practice of HBOT in chronic neurological conditions was pioneered by the late Dr. Richard Neubauer in the 1970s. Beginning with a serendipitous finding of gratuitous neurological improvement in two multiple sclerosis patients undergoing HBOT for chronic bone infections, Dr. Neubauer began applying HBOT to patients with other neurological conditions, primarily stroke. In 1994, he published his first case of HBOT treatment of chronic TBI in the Southern Medical Journal.